HYDERABAD: In what is perhaps a first, a high-level delegation of the US drug regulator US Food & Drug Administration, led by its commissioner Dr Robert M Califf visited the manufacturing facilities of Hyderabad-based active pharmaceutical ingredients (API) manufacturer Divi’s Laboratories on Tuesday.The other members of the team included USFDA’s India Country director Dr Sarah McMullen visited the company's manufacturing facility in Choutuppal on Hyderabad’s outskirts in Telangana.Divi’s Laboratories said it showcased its large-scale world-class production facilities, advanced automated manufacturing capabilities, commitment to innovation, and its crucial role...